CG Oncology (CGON) Other Working Capital Changes (2025 - 2026)
CG Oncology's (CGON) quarterly Other Working Capital Changes came in at -$329000.0 in Q1 2026, up 33.67% on a QoQ basis from -$496000.0 in Q4 2025.
CG Oncology (CGON) Other Working Capital Changes (2025 - 2026) Analysis & Trends
CG Oncology (CGON) has 2 years of Other Working Capital Changes data on file, last reported at -$329000.0 in Q1 2026.
- Quarterly Other Working Capital Changes rose 2751.43% year-over-year to $998000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 50.33% YoY) and the FY2025 annual result came in at $1.9 million, down 67.03% from the prior year.
- Other Working Capital Changes climbed to -$329000.0 in Q1 2026, from -$496000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.4 million in Q2 2024 to a low of -$320000.0 in Q3 2023.
- A 4-year average of $720583.3 and a median of $290500.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2025 — Other Working Capital Changes tumbled 101.13% — and 2026, when it soared 2751.43%.
- Tracing CGON's Other Working Capital Changes over 4 years: stood at -$320000.0 in 2023, then surged by 363.12% to $842000.0 in 2024, then soared by 114.96% to $1.8 million in 2025, then tumbled by 44.86% to $998000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $998000.0 (Q1 2026), $1.8 million (Q4 2025), and $105000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -325,000.00 |
| Jun 30, 2026 | -325,000.00 |
| Jun 30, 2026 | -325,000.00 |
| Mar 31, 2026 | -329,000.00 |
| Mar 31, 2026 | -329,000.00 |
| Mar 31, 2026 | -329,000.00 |
| Dec 31, 2025 | -496,000.00 |
| Dec 31, 2025 | -496,000.00 |
| Dec 31, 2025 | -496,000.00 |